FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

TITAN BIO-TECH LTD.

NSE : NABSE : 524717ISIN CODE : INE150C01011Industry : ChemicalsHouse : Private

BSE1212.1574.25 (+6.53 %)

PREV CLOSE (Rs.) 1137.90

OPEN PRICE (Rs.) 1162.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 39608

TODAY'S LOW / HIGH (Rs.)1125.00 1269.95

52 WK LOW / HIGH (Rs.) 373.651419

NSE

This Company is not listed in NSE

More From Company Profile

Smart Quotes

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

482.78

Dividend Yield(%)

0.16

TTM EPS (Rs.)

29.84

P/E Ratio

40.62

Book Value (Rs.)

198.95

Face Value (Rs.)

MCap (Rs. in Mn)

10016.84

Price/Earning (TTM)

34.39

Price/Sales (TTM)

5.20

Price/Book (MRQ)

6.09

PAT Margin (%)

11.68

ROCE (%)

17.80

Incorporation Year : 18-02 1992

Management Info :

Rohit Jain - Chairman Suresh Chand Singla - Managing Director

Registered Office :

Address : A - 902 A,R I I C O Industrial Area,Phase 3,
Bhiwadi,
Rajasthan-301019

Phone : 011-27355742 / 27674615

Email : hrd@titanbiotechltd.com / accounts@titanbiotechltd.com / purchase@titanbiotechltd.com

Website : www.titanbiotechltd.com / www.tmmedia.in

Registrars Details :

Beetal Financial & Computer Services (P) Ltd

Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi

Listing : BSE

NEWS

03Jan Titan Biotech informs about outcome of
Titan Biotech has informed that the Board of Directors of the Company, a..

02Jan Titan Biotech informs about record date
Further to intimation dated November 29, 2025, regarding the approval of..

22Dec Titan Biotech informs about trading wi
Titan Biotech has informed that the trading window for dealing in the se..

Financials

	QTR Dec 25	ANNUAL 25
Net Profit	78.69	182.7
Gross Profit	105.63	243.66
Operating Profit	120.86	293.38
Net Sales	565.06	1564.51

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Tatva Chintan Pharma (BSE)

1198.05 (1.41%)

M.Cap (Rs. in Cr)2802.49

Platinum Industries (BSE)

241.55 (4.75%)

M.Cap (Rs. in Cr)1326.71

Gujarat Fluorochemic (BSE)

3397.00 (0.31%)

M.Cap (Rs. in Cr)37316.05

Advance Petro (BSE)

143.70 (4.97%)

M.Cap (Rs. in Cr)12.93

Shareholding Pattern

	PROMOTERS	55.78%
	NON-INSTITUTION	44.19%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22